Construct · 1 fields · 1 citations

iRECIST: a standalone construct

One name. One construct. A landmark on the map.

● anchor · a standalone construct Nearest construct by meaning·not indexed
iRECIST1 CONSTRUCTIRECISTSEYMOUR · ONCOLOGY

A single standalone construct; nearby constructs are located against it in the Collider. Tap a field for its definition, unit, and measures.

Oncology

a modification of RECIST for immunotherapy trials that adds a category of unconfirmed progression, which must be confirmed on a later scan.

In oncology, iRECIST refers to a modification of RECIST for immunotherapy trials that adds a category of unconfirmed progression, which must be confirmed on a later scan. This meaning comes from Seymour (2017) in The Lancet Oncology.[1]

Unit
Recovery means
Measured by

Next

Run it through the Collider, or take the citations with you.

See how iRECIST sits against neighbouring constructs in the Collider, or export every reference on this page in one click.

Open in ColliderExport BibTeXReport this entry

Nearby constructs

category4 fields · 4 citationsjingle · one word, four constructsmust2 fields · 2 citationsjingle · one word, two constructsprogression3 fields · 6 citationsjingle · one word, three constructs

References

  1. Seymour, L., Bogaerts, J., Perrone, A., Ford, R., Schwartz, L. H., Mandrekar, S., Lin, N. U., Litière, S., Dancey, J., Chen, A., Hodi, F. S., Therasse, P., Hoekstra, O. S., Shankar, L. K., Wolchok, J. D., Ballinger, M., Caramella, C., & de Vries, E. G. E. (2017). iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. The Lancet Oncology, 18(3), e143-e152. https://doi.org/10.1016/s1470-2045(17)30074-8

Cited on this page?

Confirm your construct, or correct us.

If your work is cited behind one of these entries, you know better than we do whether we captured the meaning right. Confirm it, suggest an edit, or dispute it, and your name goes on the entry as an author who has checked it, linked to your ORCID.

Claim your construct